Abstract

Background

This PRISMA scoping review explored worldwide research on the delivery of suicide-specific interventions through an exclusive telehealth modality. Research over telehealth modalities with suicidal individuals highlights the importance of facilitating participants' access to treatments despite location and circumstances (e.g., rural, expenses related to appointments, etc.).

Aim

The review sought evidence of outcomes of trials or projects in which both the patient and therapist attended sessions conjointly and openly discussed suicide over a telehealth modality (e.g., phone, zoom).

Method

To explore this topic the authors searched for research trials and quality improvement projects using Ovid Medline, Ovid Embase, Ovid PsycINFO, EBSCO Social Services Abstracts, and Web of Science on 3/3/2021.

Results

Nine different articles were included that each spanned distinct treatments, with eight being research studies and one being a quality improvement project.

Limitations

Publications featuring ongoing or upcoming research in which complete study results were not available did not meet inclusion criteria for this review.

Conclusion

Several important research gaps were identified. While this approach has been largely understudied, exclusive telehealth delivery of suicide-specific interventions has great potential for the prevention of suicidality, especially in the era of COVID-19 and beyond.

中文翻译：

---

自杀和远程医疗治疗：PRISMA 范围界定审查

摘要

背景

这份 PRISMA 范围界定审查探索了全球范围内关于通过独家远程医疗方式提供针对自杀的干预措施的研究。对有自杀倾向的个人进行的远程医疗模式研究强调了促进参与者获得治疗的重要性，无论地点和环境如何（例如，农村、与预约相关的费用等）。

目的

该评价寻求试验或项目结果的证据，在这些试验或项目中，患者和治疗师共同参加会议，并通过远程医疗方式（例如，电话、缩放）公开讨论自杀。

方法

为探索该主题，作者于 2021 年 3 月 3 日使用 Ovid Medline、Ovid Embase、Ovid PsycINFO、EBSCO 社会服务文摘和 Web of Science 搜索了研究试验和质量改进项目。

结果

包括九篇不同的文章，每篇都跨越不同的治疗方法，其中八篇是研究，一篇是质量改进项目。

限制

没有完整研究结果的正在进行或即将进行的研究的出版物不符合本综述的纳入标准。

结论

确定了几个重要的研究差距。虽然这种方法在很大程度上未得到充分研究，但针对自杀的干预措施的独家远程医疗服务在预防自杀方面具有巨大潜力，尤其是在 COVID-19 及以后的时代。